4//SEC Filing
Gordon Mikael 4
Accession 0000313143-12-000058
CIK 0000313143other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 3:17 PM ET
Size
13.6 KB
Accession
0000313143-12-000058
Insider Transaction Report
Form 4
Gordon Mikael
President, Haemonetics Europe
Transactions
- Exercise/Conversion
Common Stock
2012-05-01$55.14/sh+4,000$220,560→ 10,838 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-01$72.50/sh−4,000$290,000→ 14,980 totalExercise: $55.14From: 2009-01-22Exp: 2015-01-22→ Common Stock (4,000 underlying) - Sale
Common Stock
2012-05-01$72.50/sh−4,000$290,000→ 6,838 total
Holdings
- 19,587
Non-Qualified Stock Option (right to buy)
Exercise: $52.94From: 2010-10-27Exp: 2016-10-27→ Common Stock (19,587 underlying) - 18,940
Non-Qualified Stock Option (right to buy)
Exercise: $54.99From: 2011-10-27Exp: 2017-10-27→ Common Stock (18,940 underlying) - 17,565
Non-Qualified Stock Option (right to buy)
Exercise: $61.34From: 2012-10-25Exp: 2018-10-25→ Common Stock (17,565 underlying) - 15,247
Non-Qualified Stock Option (right to buy)
Exercise: $54.55From: 2009-10-22Exp: 2015-10-22→ Common Stock (15,247 underlying)
Footnotes (3)
- [F1]Pursuant to a 10b5-1 Plan.
- [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001418808
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 3:17 PM ET
- Size
- 13.6 KB